Plasmacytoma

12 clinical trials · Condition

Record	Firm	Date
A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma (NCT04174196)	Memorial Sloan Kettering Cancer Center	2019-11-19
Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma (NCT04065308)	Seoul National University Hospital	2019-01-14
Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma (NCT03031730)	National Cancer Institute (NCI)	2018-06-14
Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma (NCT03312868)	Instituto do Cancer do Estado de São Paulo	2017-10-01
Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome (NCT02921893)	Mayo Clinic	2016-10-31
Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma (NCT02506959)	M.D. Anderson Cancer Center	2015-09-14
Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer (NCT02184533)	Stanford University	2014-07-01
Phase I/II Study of hLL1 in Multiple Myeloma (NCT00421525)	Gilead Sciences	2007-01-01
S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma (NCT00109889)	SWOG Cancer Research Network	2005-04-01

Every clearance here is in the API, with alerts when new ones post.